Expert Opinion on Emerging Drugs, pages 1-19

Exploring emerging JAK inhibitors in the treatment of aicardi-goutières syndrome

Davide Politano ^{1, 2, 3}

Davide Tonduti ^{4, 5}

Roberta Battini ^{6, 7}

Elisa Fazzi ^{8, 9}

Simona Orcesi ^{1, 2, 3}

Hide authors affiliations

Department of Brain and Behavioral Sciences, University of Pavia, Italy |

Child Neurology and Psychiatry Unit, IRCCS Mondino Foundation, Pavia, Italy

Department of Brain and behavioral sciences, University of Pavia, Pavia, Italy |

⁴

Unit of Pediatric Neurology, COALA Center for Diagnosis and Treatment of Leukodystrophies, V. Buzzi Children’s Hospital, Milan, Italy |

⁵

Department of Biomedical and Clinical Sciences, University of Milan, Milan, Italy |

⁶

Department of Developmental Neuroscience, IRCCS Stella Maris Foundation, Pisa, Italy |

⁷

Department of Clinical and Experimental Medicine, University Of Pisa, Pisa, Italy |

⁸

Department of Clinical and Experimental Sciences, University of Brescia, Brescia, Italy |

⁹

Unit of Child Neurology and Psychiatry, ASST Spedali Civili of Brescia, Brescia, Italy |

Publication type: Journal Article

Publication date: 2024-12-27

Taylor & Francis

Journal: Expert Opinion on Emerging Drugs

scimago Q1

wos Q2

SJR: 0.881

CiteScore: 5.9

Impact factor: 2.7

ISSN: 14728214, 17447623

DOI: 10.1080/14728214.2024.2445508

Copy DOI

Found

Are you a researcher?

Create a profile to get free access to personal recommendations for colleagues and new articles.

Metrics

Cite this

GOST | RIS | BibTex

Found error?

Publisher

Taylor & Francis

Journal

Expert Opinion on Emerging Drugs

scimago Q1

wos Q2

SJR

0.881

CiteScore

5.9

Impact factor

2.7

ISSN

14728214 (Print)

17447623 (Electronic)